To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PDHBTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
351 supporting clones for gene PDHB back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA461380   .a 1 to 401 400 to 1   tiling clone, Submitted on the opposite strand 400/400
(100 %)
13 diff
(96.8 %id)
NR_033384.1   .a 166 to 1761 1 to 1596   RefSeq, tiling clone, AAA   1596/1596
(100 %)
1 diff
(100.0 %id)
DB039833 testis .a 167 to 711 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
TI_57239101   .a 188 to 940 25 to 777       753/781
(96 %)
10 diff
(98.8 %id)
BI915089 brain .a 194 to 940 1 to 747       747/751
(99 %)
4 diff
(99.5 %id)
CR594405 Placenta Cot 25-normalized .a 195 to 1700 1 to 1506   tiling clone,   1506/1506
(100 %)
0 diff
(100 %id)
AL554436 placenta, Placenta Cot 25-normalized .a 195 to 1009 1 to 815   fully sequenced,   815/815
(100 %)
2 diff
(99.8 %id)
BM894536 insulinoma, Pancreas .a 206 to 749 1 to 544       544/544
(100 %)
6 diff
(98.9 %id)
BU788093 insulinoma, Pancreas .a 206 to 738 1 to 479       479/479
(100 %)
5 diff
(99.0 %id)
BG482199 choriocarcinoma, placenta .a 208 to 1068 1 to 861       861/861
(100 %)
17 diff
(98.1 %id)
BG573974 breast, mammary adenocarcinoma, cell line .a 208 to 900 1 to 694       694/694
(100 %)
3 diff
(99.6 %id)
BC004115 Placenta, choriocarcinoma .a 209 to 1761 1 to 1554   available from MGC, AAA   1552/1554
(99 %)
7 diff
(99.6 %id)
R14727 whole brain .a 212 to 373 1 to 160       160/198
(80 %)
10 diff
(95.0 %id)
BE733178 choriocarcinoma, placenta .a 228 to 867 1 to 657   available from MGC,   624/778
(80 %)
37 diff
(95.3 %id)
BE733179 choriocarcinoma, placenta .a 230 to 978 1 to 748       748/748
(100 %)
14 diff
(98.2 %id)
AL577133 placenta, Placenta Cot 25-normalized .a 948 to 1700 753 to 1   fully sequenced,   753/753
(100 %)
19 diff
(97.5 %id)
BM894261 insulinoma, Pancreas .a 1184 to 1761 596 to 19   AAA   578/578
(100 %)
0 diff
(100 %id)
BU784425 insulinoma, Pancreas .a 1315 to 1761 465 to 19   AAA   447/447
(100 %)
0 diff
(100 %id)
R42505 whole brain .a 1387 to 1566 187 to 8       180/187
(96 %)
0 diff
(100 %id)
CD685746 normal nasopharynx .b 1 to 634 15 to 648   tiling clone,   634/648
(97 %)
10 diff
(98.5 %id)
BP195693 brain .b 14 to 586 1 to 569       569/582
(97 %)
12 diff
(98.0 %id)
BG718426 testis .b 17 to 770 9 to 763   tiling clone,   755/763
(98 %)
8 diff
(99.0 %id)
BP198526 adrenal gland .b 23 to 602 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
CB999581 Pooled-Skin .b 24 to 543 1 to 529       529/830
(63 %)
26 diff
(96.9 %id)
CR595868 Neuroblastoma Cot 25-normalized .b 41 to 1543 1 to 1503   tiling clone,   1503/1503
(100 %)
0 diff
(100 %id)
AL526651 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 41 to 722 1 to 688   fully sequenced,   688/688
(100 %)
10 diff
(98.6 %id)
BM451092 eye, retinoblastoma .b 42 to 576 1 to 543       543/831
(65 %)
19 diff
(97.8 %id)
AL562722 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 690 to 1543 854 to 1   fully sequenced,   854/854
(100 %)
15 diff
(98.3 %id)
NM_000925.3   .c 1 to 1526 1 to 1526 exact RefSeq, AAA   1526/1526
(100 %)
1 diff
(100.0 %id)
BP375192 umbilical cord .c 2 to 582 1 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
BG703806 brain, hippocampus .c 13 to 768 1 to 753       753/753
(100 %)
13 diff
(98.3 %id)
DB494606 hypothalamus .c 14 to 509 1 to 496       496/496
(100 %)
4 diff
(99.2 %id)
BI857216 breast, mammary adenocarcinoma, cell line .c 14 to 839 1 to 824       824/886
(93 %)
18 diff
(98.0 %id)
CX752899 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 14 to 721 1 to 708     Submitted on the opposite strand 708/708
(100 %)
7 diff
(99.1 %id)
TI_57186883   .c 14 to 839 55 to 878       824/886
(93 %)
18 diff
(98.0 %id)
CR591704 Neuroblastoma Cot 25-normalized .c 15 to 1471 1 to 1457 exact     1457/1457
(100 %)
0 diff
(100 %id)
AL528224 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 15 to 866 1 to 851   fully sequenced,   851/851
(100 %)
1 diff
(99.9 %id)
BM923140 leukocyte .c 15 to 979 13 to 979       967/1067
(90 %)
15 diff
(98.6 %id)
BM905121 melanotic melanoma, skin .c 16 to 847 1 to 843       843/1054
(79 %)
22 diff
(98.0 %id)
CN268152 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 19 to 753 1 to 735       735/735
(100 %)
3 diff
(99.6 %id)
BF979315 testis .c 19 to 377 1 to 357   fully sequenced,   357/357
(100 %)
5 diff
(98.6 %id)
BG502539 embryonal carcinoma, testis .c 20 to 712 1 to 696       696/699
(99 %)
9 diff
(98.8 %id)
BG530830 embryonal carcinoma, testis .c 20 to 744 1 to 725       725/872
(83 %)
17 diff
(98.1 %id)
AK225621 Spleen .c 21 to 1526 1 to 1506 exact tiling clone, AAA   1506/1506
(100 %)
6 diff
(99.7 %id)
BP331610 renal proximal tubule .c 21 to 580 1 to 560       560/560
(100 %)
5 diff
(99.2 %id)
BQ070325 brain, neuroblastoma, cell line .c 22 to 974 1 to 972       972/1009
(96 %)
31 diff
(97.0 %id)
BG747836 eye, normal pigmented retinal epithelium .c 23 to 835 1 to 816       816/820
(99 %)
15 diff
(98.2 %id)
X57778   .c 25 to 1523 1 to 1499 exact     1499/1502
(99 %)
7 diff
(99.6 %id)
AK225569 lung .c 26 to 1478 1 to 1453 exact AAA   1453/1453
(100 %)
4 diff
(99.8 %id)
AK313022 alzheimer cortex .c 26 to 1123 1 to 1098 exact     1098/1098
(100 %)
1 diff
(100.0 %id)
J03576 foreskin .c 26 to 1526 1 to 1501 P213L     1501/1501
(100 %)
8 diff
(99.5 %id)
BF967069 brain, hypothalamus .c 27 to 700 1 to 667   fully sequenced,   667/667
(100 %)
16 diff
(97.7 %id)
BG036946 brain, hypothalamus .c 27 to 744 1 to 716       716/777
(92 %)
16 diff
(98.0 %id)
BG765698 melanotic melanoma, high MDR (cell line), skin .c 28 to 820 1 to 794       794/794
(100 %)
10 diff
(98.8 %id)
CR596425 placenta .c 29 to 1510 1 to 1482 exact     1482/1482
(100 %)
0 diff
(100 %id)
CR604919 Neuroblastoma Cot 25-normalized .c 29 to 1526 1 to 1498 exact tiling clone,   1498/1498
(100 %)
0 diff
(100 %id)
TI_59389874   .c 29 to 661 106 to 740       635/635
(100 %)
6 diff
(99.1 %id)
BG703833 brain, hippocampus .c 30 to 776 1 to 746       746/746
(100 %)
11 diff
(98.6 %id)
BI460407 testis .c 30 to 776 1 to 746       746/750
(99 %)
9 diff
(98.8 %id)
DR762470 embryonic stem .c 30 to 856 1 to 827       827/827
(100 %)
1 diff
(99.9 %id)
CN268136 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 31 to 778 1 to 749       749/749
(100 %)
9 diff
(98.8 %id)
TI_57229052   .c 31 to 744 90 to 804       715/716
(99 %)
6 diff
(99.2 %id)
DN989353 brain, whole brain .c 31 to 739 31 to 739       709/739
(95 %)
7 diff
(99.1 %id)
BF684121 leiomyosarcoma cell line, uterus .c 32 to 744 1 to 707       707/785
(90 %)
19 diff
(97.6 %id)
BG118878 adenocarcinoma, cell line, Liver .c 32 to 744 1 to 715       715/767
(93 %)
12 diff
(98.5 %id)
BI869588 adenocarcinoma, cell line, Liver .c 32 to 744 1 to 714       714/715
(99 %)
6 diff
(99.2 %id)
BM791198 stomach .c 32 to 732 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
ES309469 occipital hair of pubic hypotrichosispatient, skin .c 33 to 465 15 to 442       428/687
(62 %)
14 diff
(98.0 %id)
ES310128 scalp interfollicular dermis, skin .c 33 to 569 1 to 532       532/532
(100 %)
11 diff
(98.0 %id)
BM806377 leiomyosarcoma, uterus .c 33 to 974 1 to 957       957/1091
(87 %)
34 diff
(96.9 %id)
BQ949527 large cell carcinoma, lung .c 33 to 817 1 to 791       791/853
(92 %)
11 diff
(98.8 %id)
BQ921138 leiomyosarcoma, uterus .c 33 to 848 1 to 826       826/944
(87 %)
19 diff
(98.0 %id)
DR760675 embryonic stem .c 33 to 816 1 to 783       783/783
(100 %)
2 diff
(99.8 %id)
CD557082 testis .c 33 to 744 1 to 715       715/903
(79 %)
12 diff
(98.7 %id)
CX780872 human embryonic stem cells .c 33 to 866 1 to 833   fully sequenced,   833/833
(100 %)
3 diff
(99.7 %id)
TI_57214908   .c 33 to 777 65 to 819       755/819
(92 %)
25 diff
(97.0 %id)
BC000439 Lung, small cell carcinoma .c 34 to 1478 1 to 1445 exact available from MGC, AAA   1445/1445
(100 %)
2 diff
(99.9 %id)
BC001924 Lung, small cell carcinoma .c 34 to 1478 1 to 1445   available from MGC, AAA   1445/1445
(100 %)
2 diff
(99.9 %id)
BG120067 adenocarcinoma, cell line, Liver .c 34 to 744 12 to 721       710/806
(88 %)
17 diff
(97.9 %id)
BM910599 astrocytoma grade IV, cell line, brain .c 34 to 836 1 to 807       807/1091
(73 %)
13 diff
(98.9 %id)
BQ646170 hepatocellular carcinoma, cell line, Liver .c 34 to 960 1 to 929       929/931
(99 %)
26 diff
(97.3 %id)
BU849577 ovary, teratocarcinoma, cell line .c 34 to 905 1 to 875       875/875
(100 %)
6 diff
(99.4 %id)
TI_57214796   .c 34 to 819 64 to 869       806/870
(92 %)
53 diff
(94.0 %id)
BQ227508 embryonal carcinoma, cell line, testis .c 35 to 871 1 to 842       842/851
(98 %)
9 diff
(99.0 %id)
BU162269 leiomyosarcoma, uterus .c 35 to 847 1 to 816       816/901
(90 %)
15 diff
(98.4 %id)
DR155997 human embryonic stem cells differentiated toan early endodermal cell type .c 35 to 772 1 to 737       737/737
(100 %)
3 diff
(99.6 %id)
CR612410 T cells (Jurkat cell line) Cot10-normalized .c 36 to 1105 1 to 1070       1070/1070
(100 %)
0 diff
(100 %id)
BX365540   .c 36 to 554 1 to 519   fully sequenced,   519/519
(100 %)
2 diff
(99.7 %id)
BG825537 muscle, rhabdomyosarcoma .c 38 to 839 1 to 792       792/796
(99 %)
15 diff
(98.2 %id)
AH002930   .c 39 to 1523 1 to 1485 L31V     1485/1485
(100 %)
8 diff
(99.5 %id)
BI090445 cervix .c 39 to 778 1 to 738       738/739
(99 %)
13 diff
(98.3 %id)
BM459624 leiomyosarcoma, uterus .c 39 to 744 1 to 705       705/914
(77 %)
9 diff
(99.1 %id)
M34055   .c 39 to 1133 1 to 1095 L31V     1095/1095
(100 %)
4 diff
(99.7 %id)
M54788   .c 39 to 1523 1 to 1485 L31V     1485/1485
(100 %)
8 diff
(99.5 %id)
BE794689 lung, small cell carcinoma .c 40 to 839 1 to 802       802/944
(84 %)
14 diff
(98.6 %id)
BQ441004 melanotic melanoma, skin .c 40 to 834 1 to 801       801/874
(91 %)
13 diff
(98.6 %id)
BQ428365 leiomyosarcoma, uterus .c 40 to 899 1 to 865       865/866
(99 %)
16 diff
(98.2 %id)
BU509287 leiomyosarcoma, uterus .c 40 to 942 1 to 904       904/914
(98 %)
10 diff
(99.0 %id)
BQ423409 embryonal carcinoma, cell line, testis .c 41 to 833 1 to 804       804/921
(87 %)
23 diff
(97.6 %id)
CV816296 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 41 to 774 1 to 733       733/733
(100 %)
4 diff
(99.5 %id)
BM810096 amelanotic melanoma, cell line, skin .c 42 to 1074 1 to 1046       1046/1077
(97 %)
24 diff
(97.8 %id)
BM913127 amelanotic melanoma, cell line, skin .c 42 to 744 1 to 709       709/1083
(65 %)
9 diff
(99.2 %id)
BQ436280 large cell carcinoma, lung .c 42 to 979 1 to 944       942/950
(99 %)
40 diff
(95.8 %id)
BQ890605 ductal carcinoma, cell line, Pancreas .c 42 to 1016 1 to 980       978/984
(99 %)
24 diff
(97.6 %id)
BQ685611 ductal carcinoma, cell line, Pancreas .c 42 to 806 1 to 773       773/888
(87 %)
22 diff
(97.6 %id)
BQ690200 ductal carcinoma, cell line, Pancreas .c 42 to 974 1 to 942       942/942
(100 %)
24 diff
(97.5 %id)
CX867381 embryonic stem .c 42 to 866 1 to 825   fully sequenced,   825/825
(100 %)
6 diff
(99.3 %id)
CR595069 fetal liver .c 43 to 1451 1 to 1409 exact     1409/1409
(100 %)
0 diff
(100 %id)
CR597691 Neuroblastoma Cot 50-normalized .c 43 to 1466 1 to 1424 exact     1424/1424
(100 %)
0 diff
(100 %id)
AL529938 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 43 to 866 1 to 824   fully sequenced,   824/824
(100 %)
1 diff
(99.9 %id)
CR541911   .c 44 to 1120 1 to 1077       1077/1077
(100 %)
2 diff
(99.9 %id)
CR618291 Neuroblastoma Cot 25-normalized .c 44 to 1523 1 to 1480 exact     1480/1480
(100 %)
0 diff
(100 %id)
AL564605 brain, fetal liver, Liver, neuroblastoma cells .c 44 to 866 1 to 823   fully sequenced,   823/823
(100 %)
4 diff
(99.6 %id)
BE796455 lung, small cell carcinoma .c 44 to 833 1 to 788       788/904
(87 %)
14 diff
(98.5 %id)
M34479 Liver .c 44 to 1527 1 to 1484 exact     1484/1484
(100 %)
6 diff
(99.6 %id)
TI_1948076222   .c 44 to 554 133 to 643   fully sequenced,   511/643
(79 %)
7 diff
(99.0 %id)
TI_1948076403   .c 44 to 554 134 to 644   fully sequenced,   511/644
(79 %)
7 diff
(99.0 %id)
TI_1948076582   .c 44 to 663 136 to 755   fully sequenced,   620/755
(82 %)
7 diff
(99.1 %id)
TI_1948076761   .c 44 to 663 135 to 754   fully sequenced,   620/754
(82 %)
7 diff
(99.1 %id)
BQ877448 ductal carcinoma, cell line, Pancreas .c 47 to 828 1 to 794       794/972
(81 %)
22 diff
(97.8 %id)
CR597137 T cells (Jurkat cell line) Cot10-normalized .c 48 to 1450 1 to 1403       1403/1403
(100 %)
0 diff
(100 %id)
AL558457 T cells from T cell leukemia .c 48 to 774 1 to 726   fully sequenced,   726/726
(100 %)
3 diff
(99.6 %id)
BI909820 leukocyte .c 48 to 872 1 to 823       823/823
(100 %)
9 diff
(99.0 %id)
CX165788 human embryonic stem cells differentiated toan early endodermal cell type .c 48 to 877 1 to 830       830/830
(100 %)
1 diff
(99.9 %id)
TI_57237954   .c 48 to 872 31 to 853       823/853
(96 %)
15 diff
(98.3 %id)
TI_57231097   .c 48 to 631 84 to 667       584/584
(100 %)
1 diff
(99.9 %id)
CX163705 human embryonic stem cells differentiated toan early endodermal cell type .c 52 to 912 11 to 871       861/871
(98 %)
7 diff
(99.2 %id)
BF219945 lung, small cell carcinoma .c 53 to 717 1 to 656       656/703
(93 %)
14 diff
(98.1 %id)
TI_57201957   .c 54 to 778 30 to 755       726/755
(96 %)
9 diff
(98.9 %id)
BF025753 melanotic melanoma, skin .c 55 to 747 1 to 696       696/1020
(68 %)
10 diff
(99.1 %id)
BG281725 melanotic melanoma, skin .c 55 to 839 1 to 790       790/797
(99 %)
20 diff
(97.5 %id)
BI822824 pooled brain, lung, testis .c 55 to 778 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
CR604454 Placenta Cot 25-normalized .c 56 to 1466 1 to 1411       1411/1411
(100 %)
0 diff
(100 %id)
AL550950 placenta, Placenta Cot 25-normalized .c 56 to 866 1 to 811   fully sequenced,   811/811
(100 %)
1 diff
(99.9 %id)
BE267219 lung, small cell carcinoma .c 56 to 744 1 to 699       699/1105
(63 %)
20 diff
(98.2 %id)
BF308705 muscle, rhabdomyosarcoma .c 56 to 836 1 to 783       783/834
(93 %)
39 diff
(95.4 %id)
BG749485 eye, normal pigmented retinal epithelium .c 56 to 839 1 to 792       792/856
(92 %)
25 diff
(97.1 %id)
BM044181 carcinoma, cell line, Prostate .c 56 to 841 1 to 799       799/799
(100 %)
34 diff
(95.8 %id)
BM904705 leiomyosarcoma, uterus .c 57 to 964 1 to 915       915/1049
(87 %)
28 diff
(97.4 %id)
BG251223 adenocarcinoma, cell line, Liver .c 59 to 802 1 to 732       736/789
(93 %)
17 diff
(97.9 %id)
BQ706330 Spleen .c 59 to 831 1 to 778       778/934
(83 %)
10 diff
(99.0 %id)
BQ895954 carcinoma, cell line, Prostate .c 59 to 953 1 to 896       896/896
(100 %)
4 diff
(99.6 %id)
BQ919007 carcinoma, cell line, Prostate .c 59 to 932 1 to 883       881/883
(99 %)
29 diff
(96.8 %id)
BQ955076 large cell carcinoma, lung .c 59 to 933 1 to 878       878/881
(99 %)
5 diff
(99.5 %id)
BU541289 carcinoma, cell line, Prostate .c 59 to 940 1 to 890       890/915
(97 %)
12 diff
(98.7 %id)
CR625583 HeLa cells Cot 25-normalized .c 60 to 1492 1 to 1433       1433/1433
(100 %)
0 diff
(100 %id)
BI090181 cervix .c 60 to 839 1 to 789       787/864
(91 %)
19 diff
(97.9 %id)
CR617052 T cells (Jurkat cell line) .c 61 to 1467 1 to 1407       1407/1407
(100 %)
0 diff
(100 %id)
BX426408 T cells (Jurkat cell line) .c 61 to 805 1 to 744   fully sequenced,   744/744
(100 %)
3 diff
(99.6 %id)
BQ777819 Pancreas, Purified pancreatic islet .c 63 to 615 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
BQ477789 insulinoma, Pancreas .c 64 to 477 8 to 421       414/428
(96 %)
7 diff
(98.4 %id)
DN601645 human embryonic stem cells .c 68 to 867 1 to 800       800/800
(100 %)
1 diff
(99.9 %id)
CN268137 embryonic stem cells, DMSO-treated H9 cellline .c 72 to 470 1 to 399       399/399
(100 %)
0 diff
(100 %id)
BF796142 lymph, lymphoma, cell line .c 72 to 825 1 to 753       755/962
(78 %)
19 diff
(98.1 %id)
BI869678 adenocarcinoma, cell line, Liver .c 72 to 816 1 to 745       745/749
(99 %)
4 diff
(99.5 %id)
TI_57228976   .c 72 to 816 85 to 829       745/749
(99 %)
4 diff
(99.5 %id)
BG740674 skin .c 77 to 970 1 to 898       898/899
(99 %)
16 diff
(98.3 %id)
CA772200 Pancreas, Purified pancreatic islet .c 85 to 904 1 to 820       820/820
(100 %)
3 diff
(99.7 %id)
BX395105 Neuroblastoma Cot 25-normalized .c 99 to 804 62 to 770   fully sequenced,   709/770
(92 %)
7 diff
(99.1 %id)
M34056   .c 116 to 1523 1 to 1408       1408/1408
(100 %)
8 diff
(99.5 %id)
BG741383 skin .c 180 to 917 1 to 740       740/740
(100 %)
4 diff
(99.5 %id)
BG775039 carcinoma, cell line, Prostate .c 216 to 873 1 to 665   fully sequenced,   665/665
(100 %)
6 diff
(99.1 %id)
BU945195 mixed (pool of 40 RNAs) .c 234 to 1075 1 to 843       843/843
(100 %)
24 diff
(97.2 %id)
BQ377361 uterus .c 246 to 593 348 to 1       348/349
(99 %)
4 diff
(98.9 %id)
TI_154172756   .c 270 to 834 87 to 653       567/1155
(49 %)
15 diff
(98.8 %id)
CV391712 nervous_normal .c 303 to 711 412 to 5     Submitted on the opposite strand 408/412
(99 %)
1 diff
(99.8 %id)
TI_154131814   .c 305 to 1133 916 to 94   AAA   823/973
(84 %)
14 diff
(98.6 %id)
BF979861 testis .c 316 to 1039 726 to 1   fully sequenced,   726/726
(100 %)
5 diff
(99.4 %id)
BF972310 leiomyosarcoma cell line, uterus .c 328 to 1117 1 to 795       795/891
(89 %)
31 diff
(96.6 %id)
BF684082 leiomyosarcoma cell line, uterus .c 329 to 1099 1 to 780       780/929
(83 %)
26 diff
(97.3 %id)
TI_57230388   .c 346 to 837 239 to 744       506/737
(68 %)
27 diff
(96.4 %id)
BM711251 eye, fetal eyes .c 347 to 756 1 to 411       411/411
(100 %)
2 diff
(99.6 %id)
CX872436 embryonic stem .c 369 to 1177 1 to 809       809/809
(100 %)
1 diff
(99.9 %id)
BY995804   .c 374 to 1057 29 to 712       684/712
(96 %)
6 diff
(99.2 %id)
FN128997 breast carcinoma .c 381 to 475 96 to 1     Submitted on the opposite strand 96/97
(98 %)
1 diff
(99.0 %id)
CV391733 nervous_normal .c 397 to 645 1 to 249       249/249
(100 %)
3 diff
(98.8 %id)
CF454423 peripheral nervous system .c 399 to 1171 20 to 792       773/792
(97 %)
20 diff
(97.5 %id)
BX354589 Neuroblastoma Cot 25-normalized .c 414 to 1444 1027 to 5       1023/1076
(95 %)
17 diff
(98.5 %id)
FN125865 breast carcinoma .c 422 to 511 90 to 1     Submitted on the opposite strand 90/90
(100 %)
2 diff
(97.8 %id)
CA418261 Bone, Human Chondrosarcoma Cell Line .c 427 to 1133 724 to 19   AAA   706/706
(100 %)
2 diff
(99.8 %id)
CN268135 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 431 to 1174 1 to 744       744/744
(100 %)
2 diff
(99.8 %id)
TI_149303963   .c 431 to 1133 788 to 88   AAA   701/702
(99 %)
10 diff
(98.6 %id)
BU631480 cell lines, Chondrosarcoma .c 434 to 1133 717 to 19   AAA   699/699
(100 %)
2 diff
(99.8 %id)
BU623460 cell lines, Enchondroma .c 435 to 1122 705 to 18   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 688/705
(97 %)
1 diff
(99.9 %id)
BX341873   .c 440 to 1489 1060 to 10       1051/1066
(98 %)
25 diff
(97.7 %id)
BQ010252 Chondrosarcoma, Left Pubic Bone .c 451 to 1122 689 to 18   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 672/689
(97 %)
1 diff
(99.9 %id)
BU634079 cell lines, Chondrosarcoma .c 454 to 1133 697 to 19   AAA   679/679
(100 %)
2 diff
(99.8 %id)
FN104575 breast carcinoma .c 463 to 553 89 to 1     Submitted on the opposite strand 89/89
(100 %)
4 diff
(95.6 %id)
CV392853 nervous_normal .c 480 to 711 232 to 1     Submitted on the opposite strand 232/232
(100 %)
5 diff
(97.9 %id)
CA415485 Chondrosarcoma Grade II, Left Pelvis .c 482 to 1133 669 to 19   AAA   651/651
(100 %)
1 diff
(99.9 %id)
CB851105 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 493 to 1133 659 to 19   AAA   641/641
(100 %)
1 diff
(99.9 %id)
CR618835 Neuroblastoma Cot 25-normalized .c 497 to 1479 1 to 983       983/983
(100 %)
0 diff
(100 %id)
BX344514   .c 524 to 1105 582 to 1   fully sequenced,   582/582
(100 %)
6 diff
(99.0 %id)
TI_1948076223   .c 524 to 1122 722 to 124   fully sequenced,   599/722
(82 %)
0 diff
(100 %id)
TI_1948076404   .c 524 to 1122 722 to 127   fully sequenced,   596/722
(82 %)
0 diff
(100 %id)
BF037179 adenocarcinoma, ovary .c 562 to 1285 1 to 720       720/925
(77 %)
17 diff
(98.2 %id)
BM709715 eye, Retina Foveal and Macular .c 589 to 866 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
TI_154192885   .c 596 to 1531 50 to 981       932/1042
(89 %)
23 diff
(97.8 %id)
AA262634 germinal center B cell .c 597 to 1034 1 to 436   fully sequenced,   436/436
(100 %)
1 diff
(99.8 %id)
CF127470 Chondrosarcoma Lung Metastasis cell lines, lung .c 597 to 1382 1 to 785       785/785
(100 %)
3 diff
(99.7 %id)
TI_57186948   .c 597 to 1133 55 to 591   AAA   537/537
(100 %)
0 diff
(100 %id)
BI858321 breast, mammary adenocarcinoma, cell line .c 598 to 1133 1 to 536   AAA   536/536
(100 %)
0 diff
(100 %id)
BP277425 Kidney .c 601 to 1163 1 to 563       563/563
(100 %)
0 diff
(100 %id)
TI_1948076583   .c 602 to 1122 646 to 126   fully sequenced,   521/646
(80 %)
0 diff
(100 %id)
TI_1948076762   .c 602 to 1122 644 to 125   fully sequenced,   520/644
(80 %)
0 diff
(100 %id)
BM720880 eye, fetal eye .c 611 to 922 1 to 312   fully sequenced,   312/312
(100 %)
0 diff
(100 %id)
BG656557 Pancreas, Purified pancreatic islet .c 621 to 1135 516 to 2     Submitted on the opposite strand 515/523
(98 %)
1 diff
(99.9 %id)
BF967707 brain, hypothalamus .c 670 to 1406 739 to 1   fully sequenced,   741/741
(100 %)
22 diff
(97.1 %id)
BQ777528 Pancreas, Purified pancreatic islet .c 696 to 1128 452 to 20   AAA   433/438
(98 %)
3 diff
(99.4 %id)
AL580278 T cells from T cell leukemia .c 713 to 1450 737 to 1   fully sequenced,   737/737
(100 %)
5 diff
(99.4 %id)
BX351235 Neuroblastoma Cot 25-normalized .c 774 to 1518 754 to 8   fully sequenced,   747/754
(99 %)
4 diff
(99.5 %id)
BX426407 T cells (Jurkat cell line) .c 775 to 1467 690 to 1   fully sequenced,   690/690
(100 %)
10 diff
(98.6 %id)
AL563094 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 805 to 1469 667 to 3   fully sequenced,   665/667
(99 %)
0 diff
(100 %id)
AL529937 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 805 to 1466 661 to 1   fully sequenced,   661/661
(100 %)
11 diff
(98.4 %id)
AL550921 placenta, Placenta Cot 25-normalized .c 805 to 1466 663 to 1   fully sequenced,   663/663
(100 %)
4 diff
(99.4 %id)
AL564529 brain, fetal liver, Liver, neuroblastoma cells .c 805 to 1451 648 to 1   fully sequenced,   648/648
(100 %)
10 diff
(98.5 %id)
CX780811 human embryonic stem cells .c 805 to 1131 359 to 33   fully sequenced, AAA   327/328
(99 %)
3 diff
(99.1 %id)
BU733655 eye, Retina Foveal and Macular .c 805 to 1482 696 to 19   fully sequenced, AAA   678/678
(100 %)
4 diff
(99.5 %id)
CX867308 embryonic stem .c 816 to 1482 699 to 33   fully sequenced, AAA   667/667
(100 %)
10 diff
(98.6 %id)
BM666232 eye, fetal eyes .c 829 to 1478 666 to 17   AAA   650/650
(100 %)
2 diff
(99.7 %id)
BG775779 carcinoma, cell line, Prostate .c 843 to 1475 636 to 7   fully sequenced,   630/636
(99 %)
1 diff
(99.9 %id)
BQ477366 insulinoma, Pancreas .c 848 to 1526 693 to 16   AAA   678/678
(100 %)
1 diff
(99.9 %id)
BM676974 eye, fetal eye .c 892 to 1526 653 to 19   fully sequenced, AAA   635/635
(100 %)
3 diff
(99.6 %id)
GD157432   .c 972 to 1131 1 to 164   AAA   164/164
(100 %)
5 diff
(97.0 %id)
TI_157611719   .c 976 to 1479 618 to 117       502/665
(75 %)
0 diff
(100 %id)
FN091985 breast carcinoma .c 982 to 1059 78 to 1     Submitted on the opposite strand 78/79
(98 %)
0 diff
(100 %id)
TI_57171678   .c 992 to 1482 60 to 545   AAA   486/545
(89 %)
6 diff
(98.9 %id)
AA243618 germinal center B cell .c 1004 to 1386 395 to 12   fully sequenced, AAA   384/384
(100 %)
2 diff
(99.5 %id)
CN268153 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1011 to 1141 1 to 131       131/133
(98 %)
1 diff
(99.3 %id)
BF439686 pooled .c 1016 to 1118 103 to 1       103/106
(97 %)
3 diff
(97.2 %id)
BQ353311 head_neck .c 1019 to 1341 1 to 325       325/330
(98 %)
13 diff
(96.1 %id)
BE813128 amnion_normal .c 1020 to 1380 16 to 374       359/374
(95 %)
6 diff
(98.4 %id)
BF092221 testis_normal .c 1020 to 1380 11 to 370       360/370
(97 %)
6 diff
(98.4 %id)
BF886315 testis_normal .c 1021 to 1242 1 to 225       225/237
(94 %)
21 diff
(91.2 %id)
BF092158 testis_normal .c 1022 to 1380 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
FN141170 breast carcinoma .c 1028 to 1090 1 to 63       63/64
(98 %)
3 diff
(95.4 %id)
BE698489 uterus_tumor .c 1031 to 1380 351 to 3       349/351
(99 %)
0 diff
(100 %id)
EL949172 eyeball .c 1031 to 1526 565 to 70   AAA Submitted on the opposite strand 496/496
(100 %)
6 diff
(98.8 %id)
BE938596 testis_normal .c 1042 to 1380 1 to 341       341/341
(100 %)
8 diff
(97.7 %id)
BE934138 head_neck .c 1045 to 1341 1 to 297       297/302
(98 %)
8 diff
(97.4 %id)
DB510677 testis .c 1056 to 1478 1 to 423     Submitted on the opposite strand 423/423
(100 %)
4 diff
(99.1 %id)
AI537762 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1059 to 1351 288 to 1       288/297
(96 %)
11 diff
(96.3 %id)
EC440927 Prostate .c 1060 to 1134 1 to 75       75/75
(100 %)
0 diff
(100 %id)
BU077482 insulinoma, Pancreas .c 1067 to 1526 475 to 16   AAA   460/460
(100 %)
0 diff
(100 %id)
AW389453 stomach .c 1080 to 1189 110 to 1       110/110
(100 %)
1 diff
(99.1 %id)
FN050107 breast carcinoma .c 1081 to 1189 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
BU933368 mixed (pool of 40 RNAs) .c 1106 to 1531 1 to 426       426/925
(46 %)
9 diff
(99.1 %id)
FN167432 breast carcinoma .c 1118 to 1214 1 to 96       96/106
(90 %)
2 diff
(98.2 %id)
FN085324 breast carcinoma .c 1142 to 1236 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
FN160139 breast carcinoma .c 1152 to 1256 105 to 1     Submitted on the opposite strand 105/106
(99 %)
1 diff
(99.1 %id)
FN122864 breast carcinoma .c 1156 to 1265 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
BP294390 Liver .c 1159 to 1478 1 to 320   AAA   320/320
(100 %)
0 diff
(100 %id)
BE551897 pooled germ cell tumors .c 1163 to 1478 316 to 1       316/316
(100 %)
0 diff
(100 %id)
FN098958 breast carcinoma .c 1192 to 1267 75 to 1     Submitted on the opposite strand 75/76
(98 %)
2 diff
(97.4 %id)
FN101249 breast carcinoma .c 1246 to 1358 112 to 3     Submitted on the opposite strand 110/113
(97 %)
0 diff
(100 %id)
EC557554 Prostate .c 1262 to 1369 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
R20551 whole brain .c 1339 to 1521 183 to 1       183/183
(100 %)
4 diff
(97.9 %id)
FN061841 breast carcinoma .c 1354 to 1451 1 to 98       98/100
(98 %)
3 diff
(97.0 %id)
FN062258 breast carcinoma .c 1377 to 1470 11 to 104       94/104
(90 %)
12 diff
(88.5 %id)
EC469572 Prostate .c 1385 to 1481 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
FN053219 breast carcinoma .c 1408 to 1478 1 to 71       71/71
(100 %)
2 diff
(97.2 %id)
AL117618 brain .d 1 to 1437 1 to 1437 exact tiling clone, available from DKFZ, AAA   1437/1437
(100 %)
7 diff
(99.6 %id)
BI223722 cervical carcinoma cell line, cervix .d 1 to 665 1 to 666       666/666
(100 %)
5 diff
(99.3 %id)
BE543863 cervical carcinoma cell line, cervix .d 33 to 744 1 to 706       706/710
(99 %)
15 diff
(97.9 %id)
NM_001173468.1   .e 1 to 1472 1 to 1472 exact RefSeq, AAA   1472/1472
(100 %)
0 diff
(100 %id)
DB445662 testis .e 14 to 449 1 to 436   tiling clone,   436/436
(100 %)
2 diff
(99.6 %id)
AI909799 breast .e 19 to 310 297 to 6       292/316
(92 %)
7 diff
(97.8 %id)
DC357355 heart .e 21 to 419 164 to 562       399/562
(70 %)
6 diff
(99.0 %id)
AU100178   .e 21 to 320 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
AW247381 lung, small cell carcinoma .e 24 to 274 1 to 250       250/250
(100 %)
4 diff
(98.4 %id)
CB158480 Liver .e 24 to 252 1 to 229       229/229
(100 %)
0 diff
(100 %id)
DC297856   .e 35 to 593 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
AK293153   .e 35 to 1431 1 to 1397 exact tiling clone,   1397/1397
(100 %)
1 diff
(100.0 %id)
ES315089 occipital scalp hair, skin .e 51 to 218 1 to 168       168/168
(100 %)
0 diff
(100 %id)
EC560937 Prostate .e 54 to 144 18 to 107       90/107
(84 %)
8 diff
(92.6 %id)
FN168990 breast carcinoma .e 62 to 146 97 to 14     Submitted on the opposite strand 84/97
(86 %)
1 diff
(99.0 %id)
EC478285 Prostate .e 67 to 166 1 to 97       99/97
(102 %)
6 diff
(93.9 %id)
CN268154 embryonic stem cells, DMSO-treated H9 cellline .e 74 to 405 1 to 332       332/332
(100 %)
0 diff
(100 %id)
EC522951 Prostate .e 84 to 167 20 to 101       83/101
(82 %)
6 diff
(94.1 %id)
EC566359 Prostate .e 84 to 166 21 to 102       85/102
(83 %)
7 diff
(93.2 %id)
FN088409 breast carcinoma .e 85 to 177 93 to 1     Submitted on the opposite strand 93/93
(100 %)
0 diff
(100 %id)
M19123   .e 108 to 276 1 to 170       170/170
(100 %)
2 diff
(98.9 %id)
ES308320 beard hair, skin .e 124 to 286 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
FN058364 breast carcinoma .e 137 to 223 88 to 1     Submitted on the opposite strand 88/94
(93 %)
1 diff
(99.0 %id)
FN061782 breast carcinoma .e 137 to 223 88 to 1     Submitted on the opposite strand 88/94
(93 %)
1 diff
(99.0 %id)
FN063409 breast carcinoma .e 137 to 223 88 to 1     Submitted on the opposite strand 88/94
(93 %)
1 diff
(99.0 %id)
FN151196 breast carcinoma .e 154 to 245 93 to 2     Submitted on the opposite strand 92/93
(98 %)
0 diff
(100 %id)
FN166941 breast carcinoma .e 179 to 250 74 to 3     Submitted on the opposite strand 72/77
(93 %)
0 diff
(100 %id)
FN147490 breast carcinoma .e 345 to 450 1 to 111       111/111
(100 %)
9 diff
(91.9 %id)
FN071370 breast carcinoma .e 346 to 416 74 to 5     Submitted on the opposite strand 70/80
(87 %)
0 diff
(100 %id)
FN134448 breast carcinoma .e 347 to 444 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
FN111995 breast carcinoma .e 549 to 640 91 to 1     Submitted on the opposite strand 91/101
(90 %)
1 diff
(99.1 %id)
FN113422 breast carcinoma .e 550 to 650 1 to 101       101/102
(99 %)
1 diff
(99.1 %id)
BX392267 Neuroblastoma Cot 25-normalized .e 577 to 1419 847 to 1       847/936
(90 %)
28 diff
(97.1 %id)
CF128470 Chondrosarcoma Lung Metastasis cell lines, lung .e 577 to 1296 1 to 720       720/720
(100 %)
7 diff
(99.1 %id)
TI_154194352   .e 577 to 1436 51 to 909       859/1040
(82 %)
19 diff
(98.2 %id)
BX355510 Neuroblastoma Cot 50-normalized .e 581 to 1437 854 to 1       854/854
(100 %)
17 diff
(98.1 %id)
TI_154107739   .e 584 to 1424 905 to 74   AAA   832/956
(87 %)
15 diff
(98.5 %id)
BQ359241 head_normal .e 585 to 900 329 to 16       314/329
(95 %)
1 diff
(99.7 %id)
FN142929 breast carcinoma .e 586 to 671 1 to 87       87/87
(100 %)
4 diff
(95.5 %id)
TI_154110894   .e 588 to 1079 559 to 69   AAA   491/777
(63 %)
2 diff
(99.8 %id)
FN162925 breast carcinoma .e 595 to 707 108 to 1     Submitted on the opposite strand 108/108
(100 %)
5 diff
(95.4 %id)
FN160443 breast carcinoma .e 607 to 729 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
TI_59394431   .e 608 to 1387 85 to 867       783/787
(99 %)
11 diff
(98.7 %id)
DB565656 hypothalamus .e 609 to 1077 1 to 469     Submitted on the opposite strand 469/471
(99 %)
1 diff
(99.8 %id)
BM016050 breast, mammary adenocarcinoma, cell line .e 609 to 1387 1 to 782       782/786
(99 %)
11 diff
(98.7 %id)
TI_149298081   .e 613 to 1472 935 to 83   tiling clone, AAA   853/928
(91 %)
11 diff
(98.9 %id)
TI_149299849   .e 613 to 1472 930 to 80   AAA   851/977
(87 %)
18 diff
(98.2 %id)
TI_149294626   .e 617 to 1424 884 to 87   AAA   798/954
(83 %)
18 diff
(98.2 %id)
TI_149312550   .e 619 to 1420 906 to 112   AAA   795/973
(81 %)
13 diff
(98.7 %id)
FN137622 breast carcinoma .e 635 to 744 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
BM821984 stomach .e 662 to 1035 1 to 374       374/374
(100 %)
0 diff
(100 %id)
TI_154127673   .e 666 to 1422 843 to 91   AAA   753/962
(78 %)
4 diff
(99.6 %id)
BQ773557 Chondrosarcoma Cell line .e 667 to 1422 771 to 17   AAA   755/755
(100 %)
4 diff
(99.5 %id)
CN268151 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 673 to 1401 1 to 729       729/729
(100 %)
1 diff
(99.9 %id)
BQ350639 head_neck .e 681 to 1331 655 to 6       650/655
(99 %)
1 diff
(99.9 %id)
BX373973   .e 687 to 1421 735 to 1     Submitted on the opposite strand 735/918
(80 %)
8 diff
(99.2 %id)
BF220022 lung, small cell carcinoma .e 687 to 1377 689 to 1       689/747
(92 %)
10 diff
(98.7 %id)
TI_149304835   .e 687 to 1472 860 to 77   AAA   784/954
(82 %)
9 diff
(99.1 %id)
CN268140 embryonic stem cells, DMSO-treated H9 cellline .e 688 to 1410 11 to 733       724/733
(98 %)
10 diff
(98.7 %id)
BX352459   .e 688 to 1464 789 to 9       781/898
(86 %)
11 diff
(98.8 %id)
AA983337 Kidney, kidney tumor .e 690 to 1081 393 to 1       393/393
(100 %)
0 diff
(100 %id)
TI_154036044   .e 692 to 1472 865 to 86   AAA   780/953
(81 %)
9 diff
(99.1 %id)
BM791580 Ascites, stomach .e 702 to 1079 1 to 378   AAA   378/378
(100 %)
0 diff
(100 %id)
CA450398 Human Lung Epithelial cells, lung .e 706 to 1428 741 to 19   AAA   723/726
(99 %)
3 diff
(99.6 %id)
BG105379 adrenal cortex carcinoma, cell line, adrenal gland .e 713 to 1422 1 to 700   AAA   700/702
(99 %)
14 diff
(98.1 %id)
FN136680 breast carcinoma .e 714 to 776 64 to 1     Submitted on the opposite strand 64/65
(98 %)
1 diff
(98.5 %id)
BI090612 cervix .e 718 to 1079 1 to 362   AAA   362/362
(100 %)
0 diff
(100 %id)
BQ347955 head_neck .e 725 to 1113 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
FN087785 breast carcinoma .e 735 to 825 90 to 1     Submitted on the opposite strand 90/90
(100 %)
7 diff
(92.3 %id)
BU684535 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 737 to 1472 754 to 19   AAA   736/736
(100 %)
0 diff
(100 %id)
CA444281 lung, Metastatic Chondrosarcoma .e 740 to 1472 751 to 19   AAA   733/733
(100 %)
5 diff
(99.4 %id)
TI_154099448   .e 741 to 1464 817 to 93   AAA   725/1126
(64 %)
16 diff
(98.6 %id)
BU619471 Cell Line, Chondrosarcoma .e 748 to 1472 743 to 19   AAA   725/725
(100 %)
3 diff
(99.6 %id)
FN151123 breast carcinoma .e 750 to 844 1 to 95       95/95
(100 %)
0 diff
(100 %id)
TI_149282809   .e 754 to 1464 711 to 5       707/712
(99 %)
4 diff
(99.5 %id)
BU621959 Cell Line, Chondrosarcoma .e 766 to 1472 725 to 19   AAA   707/707
(100 %)
3 diff
(99.6 %id)
FN058857 breast carcinoma .e 773 to 865 91 to 1     Submitted on the opposite strand 93/91
(102 %)
3 diff
(96.8 %id)
BM971427 lung, Primary Lung Epithelial Cells .e 774 to 1472 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
BU685024 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 774 to 1472 717 to 19   AAA   699/699
(100 %)
4 diff
(99.5 %id)
FN055467 breast carcinoma .e 776 to 874 1 to 97       97/97
(100 %)
8 diff
(91.8 %id)
AA114982 uterus .e 783 to 1419 1 to 635   fully sequenced,   635/635
(100 %)
18 diff
(97.2 %id)
FN047140 breast carcinoma .e 795 to 892 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
CN268158 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 798 to 1424 637 to 11   AAA Submitted on the opposite strand 627/627
(100 %)
1 diff
(99.9 %id)
FN079866 breast carcinoma .e 802 to 874 1 to 71       71/71
(100 %)
2 diff
(97.2 %id)
AA115209 uterus .e 809 to 1425 617 to 2       616/617
(99 %)
14 diff
(97.8 %id)
BG878425 uterus .e 822 to 1273 452 to 1       452/452
(100 %)
0 diff
(100 %id)
TI_149289391   .e 825 to 1472 749 to 103   AAA   647/648
(99 %)
5 diff
(99.3 %id)
BQ350844 head_neck .e 837 to 1326 491 to 2       490/491
(99 %)
0 diff
(100 %id)
FN054621 breast carcinoma .e 858 to 954 1 to 97       97/97
(100 %)
0 diff
(100 %id)
FN062185 breast carcinoma .e 859 to 954 1 to 97       97/97
(100 %)
3 diff
(97.0 %id)
TI_57188495   .e 872 to 1427 50 to 602       553/663
(83 %)
10 diff
(98.5 %id)
TI_57188502   .e 872 to 1428 48 to 602   AAA   555/555
(100 %)
13 diff
(97.7 %id)
AW248469 lung, small cell carcinoma .e 879 to 1422 556 to 13   AAA   544/546
(99 %)
0 diff
(100 %id)
FN084028 breast carcinoma .e 885 to 961 1 to 75       75/77
(97 %)
3 diff
(96.2 %id)
FN123640 breast carcinoma .e 899 to 981 1 to 82       80/91
(87 %)
5 diff
(94.6 %id)
BM970952 lung .e 916 to 1472 575 to 19   AAA   557/557
(100 %)
0 diff
(100 %id)
AA115115 uterus .e 922 to 1425 505 to 2   fully sequenced,   504/505
(99 %)
0 diff
(100 %id)
CR596462 fetal brain .f 1 to 1616 1 to 1616 exact tiling clone,   1616/1616
(100 %)
0 diff
(100 %id)
AL534626 brain, fetal brain .f 1 to 846 1 to 846 exact fully sequenced,   846/846
(100 %)
1 diff
(99.9 %id)
BG900620 cartilage .f 517 to 838 85 to 406       323/338
(95 %)
7 diff
(98.0 %id)
AL565595 brain, fetal brain .f 816 to 1616 801 to 1   fully sequenced,   801/801
(100 %)
2 diff
(99.8 %id)
AL706543 human skeletal muscle .f 1239 to 1807 1 to 570   tiling clone,   570/570
(100 %)
5 diff
(99.2 %id)
BE302552 melanotic melanoma, skin .g 1 to 591 1 to 590 E59* tiling clone,   590/590
(100 %)
21 diff
(96.5 %id)
CB992481 placenta, pre-eclamptic placenta .h 1 to 543 32 to 572 A177E K178R I179F L180R E181D tiling clone,   545/634
(85 %)
12 diff
(98.2 %id)
DB133226 thymus .i 1 to 580 2 to 585 E48G R49K D50R E51* tiling clone, capped   584/584
(100 %)
4 diff
(99.4 %id)
DT215088 brain .j 1 to 710 1 to 710 Y76C tiling clone,   710/710
(100 %)
3 diff
(99.6 %id)
DA293101 hippocampus .k 1 to 553 2 to 555 L47X E48G R49K D50R E51* tiling clone, capped   554/556
(99 %)
2 diff
(99.7 %id)
DT216026 brain .k 11 to 585 1 to 575 exact tiling clone,   575/575
(100 %)
1 diff
(99.9 %id)
DW436462 Liver .l 1 to 199 10 to 208 A2G tiling clone, AAA   199/208
(95 %)
8 diff
(96.2 %id)
DW436463 Liver .l 1 to 199 10 to 208 A2G AAA   199/208
(95 %)
8 diff
(96.2 %id)
DW456497 Liver .l 1 to 159 10 to 168 A2G     159/168
(94 %)
7 diff
(95.9 %id)
DA232896 brain .m 1 to 556 2 to 558   tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
AB209241 brain .m 24 to 4482 1 to 4459 exact tiling clone,   4459/4459
(100 %)
7 diff
(99.9 %id)
AV684680 hepatocellular carcinoma .m 2118 to 2448 48 to 378   AAA   331/378
(87 %)
7 diff
(98.2 %id)
DA357489 subthalamic nucleus .m 2670 to 3230 2 to 562 exact capped   561/561
(100 %)
1 diff
(99.9 %id)
BI833322 pooled pancreas and spleen .m 3556 to 4377 823 to 5     Submitted on the opposite strand 819/823
(99 %)
0 diff
(100 %id)
TI_57166386   .m 3556 to 4377 853 to 35     Submitted on the opposite strand 819/853
(96 %)
0 diff
(100 %id)
CF618739 Pooled Chondrosarcoma Tumor cells .m 3634 to 4318 699 to 9   tiling clone, Submitted on the opposite strand 691/926
(74 %)
0 diff
(100 %id)
FN157479 breast carcinoma Gene PDHB, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AK311514 skeletal muscle Gene PDHB, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI